Literature DB >> 33482222

The Genomic Landscape of Actinic Keratosis.

Jason Thomson1, Findlay Bewicke-Copley2, Chinedu Anthony Anene2, Abha Gulati3, Ai Nagano4, Karin Purdie5, Gareth J Inman6, Charlotte M Proby7, Irene M Leigh5, Catherine A Harwood3, Jun Wang8.   

Abstract

Actinic keratoses (AKs) are lesions of epidermal keratinocyte dysplasia and are precursors for invasive cutaneous squamous cell carcinoma (cSCC). Identifying the specific genomic alterations driving the progression from normal skin to skin with AK to skin with invasive cSCC is challenging because of the massive UVR-induced mutational burden characteristic at all stages of this progression. In this study, we report the largest AK whole-exome sequencing study to date and perform a mutational signature and candidate driver gene analysis on these lesions. We demonstrate in 37 AKs from both immunosuppressed and immunocompetent patients that there are significant similarities between AKs and cSCC in terms of mutational burden, copy number alterations, mutational signatures, and patterns of driver gene mutations. We identify 44 significantly mutated AK driver genes and confirm that these genes are similarly altered in cSCC. We identify azathioprine mutational signature in all AKs from patients exposed to the drug, providing further evidence for its role in keratinocyte carcinogenesis. cSCCs differ from AKs in having higher levels of intrasample heterogeneity. Alterations in signaling pathways also differ, with immune-related signaling and TGFβ signaling significantly more mutated in cSCC. Integrating our findings with independent gene expression datasets confirms that dysregulated TGFβ signaling may represent an important event in AK‒cSCC progression.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33482222     DOI: 10.1016/j.jid.2020.12.024

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

Review 1.  Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients: A Systematic Review of Tumor Profiling Studies.

Authors:  Elliot D Blue; S Caleb Freeman; Marissa B Lobl; Dillon D Clarey; Rose L Fredrick; Ashley Wysong; Melodi Javid Whitley
Journal:  JID Innov       Date:  2022-03-30

Review 2.  Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma.

Authors:  Matthew L Hedberg; Corbett T Berry; Ata S Moshiri; Yan Xiang; Christopher J Yeh; Cem Attilasoy; Brian C Capell; John T Seykora
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

3.  Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).

Authors:  Zeeshaan-Ul Hasan; Ikhlaaq Ahmed; Rubeta N Matin; Victoria Homer; John T Lear; Ferina Ismail; Tristan Whitmarsh; Adele C Green; Jason Thomson; Alan Milligan; Sarah Hogan; Vanessa Van-de-Velde; Liza Mitchell-Worsford; Jonathan Kentley; Claire Gaunt; Yolande Jefferson-Hulme; Sarah J Bowden; Piers Gaunt; Keith Wheatley; Charlotte M Proby; Catherine A Harwood
Journal:  Br J Dermatol       Date:  2022-06-14       Impact factor: 11.113

Review 4.  Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma.

Authors:  Glenn Geidel; Isabel Heidrich; Julian Kött; Stefan W Schneider; Klaus Pantel; Christoffer Gebhardt
Journal:  NPJ Precis Oncol       Date:  2022-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.